Living with Low Platelets?
You Don't Have to Face ITP Alone

A normal platelet count ranges from 150,000 to 400,000 per microliter of blood. For ITP, counts often fall below 100,000/µL. A platelet count below 30,000/µL is generally considered serious, as it increases the risk of spontaneous bleeding — such as nosebleeds, gum bleeding, or internal bruising. Counts below 10,000/µL can be life-threatening and may require emergency treatment. If you're experiencing symptoms of low platelets, it's important to consult a haematologist promptly.

Treatment for ITP depends on platelet count severity and symptoms. Options include corticosteroids (like prednisone) as a first-line treatment, intravenous immunoglobulin (IVIG) for rapid platelet boosts, and TPO-receptor agonists (such as eltrombopag and romiplostim) that stimulate platelet production. In some cases, rituximab or splenectomy may be considered. Clinical trials also offer access to emerging therapies. Our team can help you understand which options may be right for your situation.

Yes, ITP can go into remission. In children, ITP often resolves on its own within 6 to 12 months. In adults, some people experience spontaneous remission, while others achieve stable platelet counts through treatment. Chronic ITP (lasting more than 12 months) may require ongoing management, but many patients find effective treatments that allow them to live full, active lives. New therapies and clinical trials continue to improve remission rates and quality of life.

Clinical trials give ITP patients access to cutting-edge treatments — including new TPO-receptor agonists, immunomodulators, and targeted therapies — that may help raise platelet counts more effectively than current options. Participants receive close monitoring from leading haematologists and contribute to advancing ITP research. Know Rare's support team can match you with ITP-specific clinical trials based on your platelet levels, treatment history, and location — at no cost to you.

No. Know Rare's support services are completely free for patients and caregivers. Our team will connect you to ITP specialists, clinical trials, and resources at no cost to you. We believe everyone living with a rare condition deserves access to the best care and support, regardless of financial circumstances.